Wordt geladen...
Relapsed and refractory primary CNS lymphoma: treatment approaches in routine practice
Despite recent therapeutic progress and improved survival for many patients with primary central nervous system lymphoma (PCNSL), up to 50% of patients will experience refractory or relapsed disease following first-line treatment with high dose methotrexate (HD-MTX) based regimens. The majority of s...
Bewaard in:
| Gepubliceerd in: | Ann Lymphoma |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7612457/ https://ncbi.nlm.nih.gov/pubmed/35253010 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/aol-21-20 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|